Ab&b Bio-tech Co., Ltd.js

This study tests a rabies vaccine using different shot schedules to see if fewer doses still provide strong protection. About 3,000 healthy people aged 10 to 60 will receive the vaccine in one of five schedules, including a standard 5-dose plan and shorter 4-dose options. Researc…

This study tests a new recombinant shingles vaccine in 960 healthy adults aged 40 and older. The goal is to check the vaccine's safety and how well it boosts the immune system against the shingles virus. Participants receive the vaccine and are monitored for side effects and immu…

This early-stage study tested whether a new flu vaccine with an added booster (adjuvant) is safe for people 65 and older. 80 volunteers received the vaccine and were monitored for side effects over a year. The goal was to check for any immediate or long-term reactions, not yet to…

This early-stage trial tested the safety of a new flu vaccine with an added ingredient (adjuvant) to boost immune response. It involved 80 volunteers aged 65 and older, who were monitored for side effects over 12 months. The goal was to see if the vaccine is safe enough for furth…